Healthcare provider profile · identity verified

Dallin R. Olson, MD

Family Practice · MUNCIE, IN · NPI 1770964751

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	456	130
Lisinopril	Lisinopril	334	98
Amlodipine Besylate	Amlodipine Besylate	234	70
Levothyroxine Sodium	Levothyroxine Sodium	220	54
Losartan Potassium	Losartan Potassium	170	50
Omeprazole	Omeprazole	165	48
Metformin Hcl Er	Metformin Hcl	150	37
Pantoprazole Sodium	Pantoprazole Sodium	141	41
Hydrochlorothiazide	Hydrochlorothiazide	131	34
Fluoxetine Hcl	Fluoxetine Hcl	123	29
Trazodone Hcl	Trazodone Hcl	121	31
Tamsulosin Hcl	Tamsulosin Hcl	115	37
Gabapentin	Gabapentin	111	36
Metformin Hcl	Metformin Hcl	108	31
Metoprolol Succinate	Metoprolol Succinate	107	31
Jardiance	Empagliflozin	88	14
Potassium Chloride	Potassium Chloride	87	23
Furosemide	Furosemide	82	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	15
Alendronate Sodium	Alendronate Sodium	73	28
Zolpidem Tartrate	Zolpidem Tartrate	68	13
Rosuvastatin Calcium	Rosuvastatin Calcium	66	21
Fluticasone Propionate	Fluticasone Propionate	65	27
Eliquis	Apixaban	62	14
Famotidine	Famotidine	60	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	11
Montelukast Sodium	Montelukast Sodium	60	17
Celecoxib	Celecoxib	59	21
Carvedilol	Carvedilol	57	15
Bupropion Xl	Bupropion Hcl	55	14
Tramadol Hcl	Tramadol Hcl	55	11
Glimepiride	Glimepiride	52	13
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Finasteride	Finasteride	49	12
Simvastatin	Simvastatin	48	12
Escitalopram Oxalate	Escitalopram Oxalate	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	21
Donepezil Hcl	Donepezil Hcl	44	suppressed
Ozempic	Semaglutide	44	suppressed
Xarelto	Rivaroxaban	44	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Pregabalin	Pregabalin	39	suppressed
Prednisone	Prednisone	37	26
Allopurinol	Allopurinol	35	11
Albuterol Sulfate Hfa	Albuterol Sulfate	34	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Cephalexin	Cephalexin	33	22
Meloxicam	Meloxicam	33	suppressed
Rizatriptan	Rizatriptan Benzoate	33	suppressed
Azithromycin	Azithromycin	31	29
Clopidogrel	Clopidogrel Bisulfate	28	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	17
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	20
Sertraline Hcl	Sertraline Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Estradiol	Estradiol	23	suppressed
Glipizide	Glipizide	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Lorazepam	Lorazepam	23	11
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Rybelsus	Semaglutide	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Fluconazole	Fluconazole	20	15
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Naproxen	Naproxen	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Glipizide Er	Glipizide	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Atenolol	Atenolol	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error